Overview
Karim Mahawish practices in Auckland, New Zealand. Mr. Mahawish is rated as an Experienced expert by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Stroke, Alien Hand Syndrome, Carotid Artery Disease, Hypertension, and Thrombectomy.
His clinical research consists of co-authoring 45 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Diffuse Large B-Cell Lymphoma (DLBCL).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Alien Hand SyndromeMr. Mahawish isAdvanced. Learn about Alien Hand Syndrome.
- StrokeMr. Mahawish isAdvanced. Learn about Stroke.
- ThrombectomyMr. Mahawish isAdvanced. Learn about Thrombectomy.
- Experienced
- Acute Cerebellar AtaxiaMr. Mahawish isExperienced. Learn about Acute Cerebellar Ataxia.
- ApraxiaMr. Mahawish isExperienced. Learn about Apraxia.
- Atrial FibrillationMr. Mahawish isExperienced. Learn about Atrial Fibrillation.
- Carotid Artery DiseaseMr. Mahawish isExperienced. Learn about Carotid Artery Disease.
- Creutzfeldt-Jakob DiseaseMr. Mahawish isExperienced. Learn about Creutzfeldt-Jakob Disease.
- Diffuse Large B-Cell Lymphoma (DLBCL)Mr. Mahawish isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).